Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes

Cannabis and Cannabinoid Research - United States
doi 10.1089/can.2016.0009
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

Irritable Bowel Syndrome: A Dysfunction of the Endocannabinoid System?

Gastroenterology
HepatologyGastroenterology
2012English

Combination of Irritabl Bowel Syndrome With Fibromyalgia and the Efffect of Irritable Bowel Syndrome Treatment on Both

International Journal of Surgery Science
2019English

Clinical Potential of Eluxadoline in the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome

Therapeutics and Clinical Risk Management
2016English

Research Progress in Fecal Microbiota Transplantation as Treatment for Irritable Bowel Syndrome

Gastroenterology Research and Practice
HepatologyGastroenterology
2019English

Clinical and Experimental Study on Probiotics in the Treatment of Constipation Type Irritable Bowel Syndrome

Biomarkers and Applications
2019English

Evaluation of Drug Treatment in Irritable Bowel Syndrome

British Journal of Clinical Pharmacology
Pharmacology
2003English

Eluxadoline in the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2017English

Serotonin Receptor Modulators in the Treatment of Irritable Bowel Syndrome

Therapeutics and Clinical Risk Management
2008English

The Irritable Bowel Syndrome.

Postgraduate Medical Journal
Medicine
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy